🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Trump suggests White House staff will wait longer for COVID-19 vaccines

Published 2020-12-13, 05:13 p/m
© Reuters. U.S. President Trump hosts Serbia's President Vucic and Kosovo's Prime Minister Hoti at the White House in Washington
PFE
-

By Steve Holland and David Shepardson

WASHINGTON (Reuters) -U.S. President Donald Trump suggested late Sunday that senior White House officials would wait longer for COVID-19 vaccines hours after media outlets reported senior officials were to receive doses within 10 days.

Late Sunday night, Trump said on Twitter he had asked for an "adjustment" to be made to the plans to vaccinate White House officials.

"People working in the White House should receive the vaccine somewhat later in the program, unless specifically necessary," Trump wrote, adding: "I am not scheduled to take the vaccine, but look forward to doing so at the appropriate time."

Reuters reported earlier Sunday that Trump, Vice President Mike Pence and other top U.S. officials would be offered the newly approved COVID-19 vaccine beginning on Monday as part of a plan aimed at ensuring continuity of government, a source familiar with the plan said.

Essential personnel at the White House and certain officials in all three branches of government were set to be vaccinated within the next 10 days, said the source.

Trump previously contracted the novel coronavirus and recovered. Many White House officials have already had COVID-19, potentially dampening their need for quick access to the vaccine.

National Security Council spokesman John Ullyot said before Trump's tweet that senior officials in the executive branch, Congress and judiciary would receive vaccinations in line with a protocol aimed at ensuring the U.S. government can continue to operate during a pandemic or catastrophic emergency.

"The American people should have confidence that they are receiving the same safe and effective vaccine as senior officials of the United States government on the advice of public health professionals and national security leadership," Ullyot said in a statement.

It was also not clear whether President-elect Joe Biden, Vice President-elect Kamala Harris and other members of Biden's transition team would be offered vaccinations.

In September, Pence told the Hill newspaper: "The very moment that it's appropriate for somebody in my category to get a vaccine, you better believe it. I, and my family, wouldn't hesitate."

A U.S. Centers for Disease Control and Prevention advisory panel on Saturday recommended the nation's first COVID-19 vaccine developed by Pfizer Inc (NYSE:PFE) and BioNTech SE, as the U.S. COVID-19 death toll topped 298,000.

Doses of the vaccine will reach 145 locations across the country on Monday, with initial shots to go to healthcare workers and elderly residents of long-term care homes.

A senior administration official said a comprehensive "National Continuity Policy" was established by the administration of former President Barack Obama in July 2016.

© Reuters. U.S. President Trump hosts Serbia's President Vucic and Kosovo's Prime Minister Hoti at the White House in Washington

"This will further ensure that the United States government will continue essential operations, without interruption, for our citizens as we continue to fight this pandemic and work toward a return to prosperity for our nation," the official said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.